If the headline, pricing, visuals, or phrasing leaves consumers thinking FDA-approved or equivalent to Wegovy, disclaimers buried later will not cure the overall net impression.
The semaglutide plateau that many users hit around months four through six is often partly explained by this metabolic slowdown
Still, the analysts predicted that Ozempic, Wegovy, and Rybelsus (semaglutide) maker Novo Nordisk and Eli Lilly, which developed Zepbound and Mounjaro (tirzepatide), will maintain two-thirds of the market by 2031 due to their first-mover advantages. Other competitors are expected to take a combined $70 billion of the GLP-1 market, the study read
Nora Volkow, who runs the National Institute of Drug Abuse, are the corresponding authors for the study, which is based on patient health records and published in Nature Communications
Patients who follow these aftercare steps often see remarkable improvements in just a few months, with scars fading into near-invisibility
Qi C, Wang Y, Li P, Zhao J